After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Zevra Therapeutics Inc is $489.38M. A total of 0.51 million shares were traded on the day, compared to an average of 540.33K shares.
In the most recent transaction, Watton Corey Michael bought 300 shares of ZVRA for 7.84 per share on Mar 28 ’25. After the transaction, the Director now owns 1,800 company shares. In a previous transaction on Mar 19 ’25, Bode John B bought 10,000 shares at 7.96 per share. ZVRA shares that Director owns now total 40,000.
Among the insiders who sold shares, Sangiovanni Timothy J. disposed of 3,000 shares on Feb 13 ’25 at a per-share price of $7.86. This resulted in the SVP, Finance & Corp Controller holding 16,341 shares of ZVRA after the transaction. In another insider transaction, Schafer Joshua sold 10,500 shares at $7.86 per share on Feb 13 ’25. Company shares held by the CCO & EVP, Bus. Development now total 29,486.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ZVRA has a high of $9.76 and a low of $4.20.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZVRA’s latest balance sheet shows that the firm has $112.35M in Cash & Short Term Investments as of fiscal 2021. There were $1.61M in debt and $4.23M in liabilities at the time. Its Book Value Per Share was $0.75, while its Total Shareholder’s Equity was $127.12M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock.
